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diameter of primary mass was ranging from 10 to 119 mm (mean ± SD, 
44 ± 22 mm). Pleural or pericardial effusion was identiﬁed on 58 cases 
and pleural nodules without pleural effusion suggesting dry pleural 
seeding were identiﬁed in 8 cases. Pulmonary metastasis was found in 
74 patients (56%) showing micronodular in 27 cases, macronodular 
in 23 cases and lymphangitic carcinomatosis in 44 cases. Thirty-one 
of the 74 patients with pulmonary metastases showed unilateral lung 
metastases. Only 34 of the 132 patients showed no evidence of distant 
metastases. 
Conclusion: The majority of lung cancer under age 40 was adenocar-
cinoma and stage IV. Although we could not ﬁnd speciﬁc radiologic 
features, unilateral pulmonary metastasis was common in this age 
group. This study suggested that young patients under age 40 with lung 
cancer often present with unilaterally advanced disease.
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Background: Cavitation within lung tumors, either spontaneous or 
secondary to chemotherapy, has been documented by several reports. 
However, to our knowledge, there have been few reports of radiologic 
ﬁndings of cavitary change of miliary pulmonary metastases follow-
ing chemotherapy. The aim of this study was to describe CT ﬁndings 
of thin walled cavitary changes of miliary pulmonary metastases from 
primary lung cancer following chemotherapy.
Methods: Between 2001 and 2006, six patients (male-female ratio, 3:3; 
mean age, 53 years; age range, 44-63 years) with thin-walled cavitary 
change of miliary pulmonary metastases from primary lung cancer 
following chemotherapy were identiﬁed at our hospital. We deﬁned 
thin wall as less than 5-mm in wall thickness of nodule. We retrospec-
tively reviewed histology of primary lung cancer and chemotherapeutic 
agents for treatment. CT ﬁndings were assessed in terms of the relation-
ship of cavity with metastatic nodules, change of size of nodule and 
cavity, and parenchymal change. 
Results: The histology of primary lung cancer was adenocarcinoma 
in all patients. The patients were treated with a variety of chemothera-
peutic agents (irinotecan, cisplatin, gemcitabine, navelbine, taxotere, 
iressa, etc). Primary lung cancer with diameters ranging from 27 to 80 
mm (mean ± SD, 55 ± 21 mm), were identiﬁed in 5 patients. Cavitary 
changes of primary lung cancer prior to chemotherapy were found in 3 
of the 5 patients.
Thin walled cavitary change of pulmonary metastases after chemo-
therapy was identiﬁed on 6 cases. The thin-walled cavity was located 
within the preexisting metastatic pulmonary nodule (n=3) and adjacent 
to the preexisting metastatic pulmonary nodule (n=3). The cavity was 
markedly increased in size on follow-up CT scans in 2 patients with 
underlying emphysema and no signiﬁcant change in 4 patients. The 
shape of the cavity of pulmonary metastases was round (n=1) or irregu-
lar (n=5). The size of the cavity of pulmonary metastases was uniform 
(n=1) or various (n=5). Two of the six patients showed structural distor-
tion of lung parenchyma on follow-up CT scans after chemotherapy.
Conclusions: Thin-walled cavitary change of pulmonary metastases 
from primary lung cancer following chemotherapy was identiﬁed and 
the cavities were located inside or adjacent to preexisting metastatic 
nodule. Marked increase in size of the cavity and structural distortion 
of lung parenchyma on follow-up CT after chemotherapy were founded 
in 2 patients. These CT ﬁndings support the previously reported mecha-
nisms of cavitary change of pulmonary nodules: necrosis of the tumor 
metastases, check-valve mechanism and cystic dilatation of bronchus 
due to ﬁbrotic change of healing peribronchial nodules. 
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Background: To assess the clinical value of computed topography 
(CT) guided transthoracic needle aspiration (TTNA) in pulmonary 
lesions. 
Methods: To summarize 50 patients with lung lesions who underwent 
surgery, before that we performed TTNA, then analyzed its’ sensitivity, 
speciﬁcity and complications. 
Result: We got tissue in each case successfully among them 40 were 
malignant (17 squamous carcinoma,14 adenocarcinoma, 3 small cell 
lung cancer,6 undeﬁned carcinoma), 10 bingn. All were testiﬁed by 
surgery 10 infections or normal lung tissue turned to be false negative 
in 5 cases,sensitivity 88.8%,speciﬁsity100%. 5 had complications of 
pneumothorax, 1 of them underwent closed drainage, 5 got coughing 
up blood, however recoverd rapdliy after hemostatic treatmnet. 
Conclusion: CT guided transthoracic needle aspiration is a easy,safe 
and reliable method for lung lesions diagnosis.
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Background: To retrospectively investigate and compare the useful-
ness of trans-thoracic ﬁne needle aspiration (FNA) and core needle 
biopsy (CNB) in the diagnosis of pulmonary lesions. 
Methods: Sixty-nine consecutive CT-guided lung biopsies were per-
formed in 60 patients between Dec 1998 and Dec 2005 and 30 patients 
underwent CNB (with an automated 18-G core biopsy needle and a 
gun) and FNA (with a 22-G needle) procedures respectively, either 
ﬁne-needle aspirate samples for cytology or core biopsy samples for 
histology were collected. Of these, a ﬁnal diagnosis was obtained in 
all lesions with surgery, then analyzed its’ sensitivity, speciﬁcity and 
complications. 
Results: Core biopsy yielded a correct diagnosis was obtained in 25 
procedures (89.3%) for malignant leisons. Aspiration biopsy yielded 
a correct diagnosis in 24 procedures (88.8%) for malignant leisons. 
Pneumothorax occurred in 4/30 (13.3%) patients with core biopsy and 
in 2/30(6.6%) patients with aspiration biopsy. Of these, one with core 
biopsy needed tube drainage. The other complication was haemoptysis, 
which occurred in ﬁve patients following core biopsy and in two after 
aspiration biopsy. All seven cases subsided spontaneously. There were 
no fatal complications.
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Conclusion: Core biopsy with a biopsy gun increase the diagnostic 
accuracy with a higher histologic predictive rate and no obvious ad-
ditional risk of complications.
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Background: In lung cancer, stage has classically been the most 
important prognostic factor for disease progression and survival. How-
ever, stage may be simply a surrogate for underlying tumor burden. The 
purpose of this study was to assess the prognostic value of pre-treat-
ment tumor volume as measured by FDG-PET imaging.
Methods: We identiﬁed a cohort of 19 patients with lung cancer who 
had staging PET-CT scans prior to any therapy, and adequate follow-
up. Follow-up was complete to the time of progression for 18 of 19 
patients, and to the time of death for 15 of 19 patients. Four patients 
remain alive. We used custom software to segment metabolically active 
tumor regions semi-automatically on PET scans. We determined the 
relationship between time to progression (TTP) and two PET param-
eters: total metabolic tumor volume (MTV), and standardized uptake 
value (SUV).
Results: The median TTP for the cohort was 8.6 months (range 0.7-
25). The median overall survival (OS) was 15 months. The median 
MTV was 27 mL. On multivariate Cox proportional hazards regression 
analysis, an increase in MTV of 25 mL (the difference between the 75th 
and 25thpercentiles) was associated with a 2.6 fold increase in hazard 
of progression, statistically signiﬁcant (p=0.023) after controlling 
for stage, age, KPS, and weight loss. Figure 1 shows the relationship 
between MTV and progression-free survival. Similarly, an increase in 
MTV of 25 mL was associated with a 2.9 fold increase in the hazard 
of death (p=0.0017). We did not ﬁnd a signiﬁcant relationship between 
SUV and TTP or OS.
Conclusions: In this study, high tumor burden assessed by PET MTV 
is a poor prognostic feature in lung cancer independent of stage, age, 
KPS, and weight loss. This may be promising for stratifying patients in 
randomized trials, and ultimately for selecting risk-adapted therapies. 
These results will need to be validated in larger cohorts with longer fol-
low-up, as well as evaluated prospectively.
Figure 1
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Background: The integration of computed tomography (CT) and 
FDG-PET provides better speciﬁcity and sensitivity in tumor imaging 
than either component alone. We prospectively evaluated FDG-PET/
CT as a method for determining surgical indications in patients with 
primary lung cancer. 
Methods: Consecutive patients with a diagnosis of primary lung cancer 
based on preoperative cytology or histologic examination in our hospi-
tal were enrolled prospectively. Conventional disease staging was per-
formed using chest CT, abdominal CT, brain magnetic resonance imag-
ing (MRI), and bone scintigraphy. Treatment strategy was determined 
based on conventional staging. Independently, simultaneous PET-stag-
ing was performed based on whole body FDG-PET/CT and brain MRI. 
Results of preoperative PET were compared with surgical specimens of 
hilar and mediastinal lymph nodes. In nonsurgical cases, node (N) and 
metastasis (M) factors diagnosed by PET were evaluated based on the 
clinical course or results from biopsy specimens of speciﬁc sites. 
Results: Twenty men and 22 women, age range, 47 to 87 years (71±10, 
mean±SD), were enrolled. Histology included 27 adenocarcinomas, 10 
squamous cell carcinomas, and 5 small cell carcinomas. Clinical stage 
by conventional staging was c-stages IA or B in 13, IIA or B in 3, IIIA 
in 6, IIIB in 7, and IV in 13. According to the conventional staging, 
16 patients underwent surgery. By PET-staging, 9 cases (21%) were 
